Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009
...n of Risperdal(R) M-TAB, during the second quarter, and was the exclusive supplier of .25mg, 3mg and 4mg strengths of the product during the period. risperdal
M-TAB had $108.0 million in annual sales in 2008 according to IMS Health.
Par also launched calcitonin-salmon nasal spray, the generic versio...
New tool to improve patient understanding of long-acting injectable antipsychotic therapies (LAT) unveiled in April issue of Psychiatry 2009
Risperidone long-acting therapy (RLAT, or risperdal
CONSTA), for the treatment of symptoms of schizoph...everal long-acting injectable products available. risperdal
CONSTA is the only long-acting injectable form of ... as atypical antipsychotics approved in the U.S. risperdal
CONSTA is a proven medicine with an innovative del...
New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia
... IMPORTANT SAFETY INFORMATION FOR CONSUMERS ABOUT risperdal
(R) CONSTA (R)
Elderly Patients with dement...y to achieve an erection.
Some people taking risperdal
(R) CONSTA (R) may feel faint or lightheaded whe... you start therapy with RISPERDAL(R) CONSTA.
(R) CONSTA (R) may affect your alertness or driv...
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
...nce of other causative factors, discontinuation of risperdal
Consta should be considered.
Potential for C...ons and features are consistent with NMS.
Consta with caution in patients with conditions an...ent.
Commonly Observed Adverse Reactions for risperdal
(R) CONSTA (R) : The most common adverse react...
Johnson & Johnson Reports 2009 First-Quarter Results:
... treatment of a number of immune mediated inflammatory diseases; INVEGA and risperdal
CONSTA, both antipsychotic medications; and VELCADE, a treatment for multip... 275 809 -66.0% -64.2% -1.8%
US 126 101 ...
Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results
...a number of immune mediated inflammatory diseases; risperdal
CONSTA, an antipsychotic medication; and TOPAMAX, ... 874 -67.4% -66.5% -0.9%
US ... 3,420 -37.8% -39.3% 1.5%
Johnson & Johnson Reports 2008 Third-Quarter Results:
...STA, an antipsychotic medication. Sales results of risperdal
negatively impacted by generic competition.
...831 -61.5% -63.0% 1.5%
CONSTA ---------------- US 118 ... 2,546 -27.7% -30.0% 2.3%
CONSTA ---------------- US 339 ...
Janssen Announces Launch of Authorized Generic for RISPERDAL(R)
...AL, which was first approved by the FDA in 1993.
(risperidone) is indicated for the treatment of sc...der in children and adolescents
aged 5-16 years.
(risperidone) is indicated for the short-term trea...re and potentially fatal
side effect reported with risperdal
and similar medicines. Call your doctor
Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake
...(GSK), Coversyl (Servier), Micardis (Boehringer- Ingelheim), Spiriva (Boehringer-Ingelheim) Mental Health: Zyprexa (Lilly), Efexor (Wyeth), risperdal
(J&J) Alzheimer's disease: Aricept (Pfizer), Reminyl (Shire) Men's health: Cialis (Lilly), Levitra (Bayer-Schering), Viagra (Pfizer), ...
Antipsychotics Dangerous for Elderly With Dementia
...sed to treat some of the behavioral complications of dementia, including delirium.
Newer antipsychotic medications such as Zyprexa (olanzapine) and risperdal
(risperidone) have been available for about a decade and have largely replaced their older counterparts.
Researchers from the Institute for Clinica...
Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder
...daq: ALKS ). Available in 12.5 mg, 25 mg, 37.5 mg and 50
mg dose units, it is approved for the treatment of schizophrenia. For more
information about risperdal
CONSTA, visit http://www.risperdalconsta.com .
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is
based in Titusville, N.J. and is...
Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
...tient share in all
lines of therapy, largely owing to its first-in-class status among the
antipsychotics to treat both mania and depression. Janssen's risperdal
Eli Lilly's Zyprexa suffered the greatest losses, losing a combined 11.9%
patient share first line over the same time period. About Treatment Alg...
FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
...60 children and
adolescents, ages 10-17, for the short-term treatment of bipolar mania
associated with manic or mixed episodes of bipolar I disorder. risperdal
is marketed in the U.S. by Janssen, L.P. and promoted by
McNeil Pediatrics, a division of McNeil-PPC., Inc. Janssen is the only U.S. pharmaceutical c...
Big Pharma's continued hunger and search for new products
... Merck) Cholesterol Reduction $5.3 6. Norvasc (Pfizer) Hypertension/Angina $5.0 +3% 7. Zyprexa (Eli Lily) Antidepressant $4.7 8. risperdal
(Janssen- Ortho/J&J) Anti-psychotic Agent $4.0 +13% 9. Prevacid (Abbott/Takeda) Gastrointestinal Disorders $4.0 +1% 10. Effexor (Wyeth) A...